UNSPSC 51332526: Pipamperone hydrochloride

This classification denotes an anxiolytic with the molecular formula C21H30FN3O2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IT085U64JB, chemically known as 1-(3-(p-fluorobenzoyl)propyl)-(1,4-bipiperidine)-4-carboxamide but more generally known as pipamperone hydrochloride, which bears US NIH Compound Identifier 4830. European Medicines Agency schedules Pipamperone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03835MIG.

Most nations, for tariff and trade purposes, schedule pipamperone hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, PIPAMPERONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CC(CCC1C(=O)CCCN2CCC(CC2)(C(=O)N)N3CCCCC3)F.CL.CL.

UNSPSC 51332526 Pipamperone hydrochloride is a Commodity code representing pharmaceutical products, though the recent state and local procurement activity tagged under this code shows a significant mismatch with the nominal scope. The single recent opportunity in the dataset involves Naloxone and drug deactivation systems rather than pipamperone hydrochloride specifically, suggesting either a tagging error or broader pharmaceutical procurement under this code designation. State and local governments procuring under this code appear to be purchasing emergency medical supplies and harm-reduction pharmaceuticals to support community health and public safety initiatives, with issuing bodies including county health departments and county government procurement offices.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023. The procurement requires quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping and delivery costs, electronic bid submission through the county's e-procurement portal, drug-free workplace certification, and E-Verify compliance. The contract carries a two-year initial term with an optional one-year renewal and includes a three-month probationary termination clause. Potential FEMA funding introduces additional federal compliance requirements. The code shows limited recent activity in the dataset, with this single opportunity representing the visible market signal for state and local pharmaceutical procurement in this category.